ENALAPRILAT
NDC 51662-1477, ENALAPRILAT, injection, from HF Acquisition Co LLC, DBA HealthFirst.
- Product NDC
- 51662-1477
- Status
- Listed
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078687
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1477 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ENALAPRILAT1.25 mg/mL
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Decreased Blood Pressure [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51662-1477-1 | 51662147701 | 1 mL in 1 VIAL (51662-1477-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9d88f915-13dd-5463-e053-2a95a90a09bf
Use it
Look up 51662-1477 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1477 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51662-1477. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.